Founding Dean of UC San Diego Rady School of Business Joins Releviate Therapeutics’ Board of Directors

Business Wire

Published

SAN DIEGO--(BUSINESS WIRE)--Releviate Therapeutics, a bio-pharmaceutical company addressing the needs of patients suffering from chronic pain, today welcomes Robert Sullivan, founding dean emeritus of UC San Diego’s Rady School of Management, as a director on its board. Sullivan brings Releviate over 30 years of experience in entrepreneurship, technology innovation and operations management. As a part of the board, he will manage investor relations and strategize with other directors on opportu

Full Article